"The Report H5N1 Infection
(Avian Influenza) Global Clinical Trials Review, H1, 2016 provides
information on pricing, market analysis, shares, forecast, and
company profiles for key industry participants. -
MarketResearchReports.biz"
MarketResearchReports.biz has
announced the addition of a new report, titled “H5N1
Infection (Avian Influenza) Global
Clinical Trials Review, H1, 2016.” The research study offers a
360-degree overview of clinical trials on H5N1 (avian influenza)
conducted worldwide.
H5N1 is considered a highly
pathogenic bird flu virus. This virus has led to dangerous outbreaks
in domestic poultry in regions such as the Middle East and Asia. This
virus has the ability to produce diseases, although it does not
usually infect humans. Nevertheless, according to the WHO, around 650
human cases of avian flu have been reported in over 15 countries
since 2003. Out of these, 60% of the cases died due to their illness.
Hence, this virus is considered to be highly pathogenic.
H5N1 clinical trials are intended
to offer immunization against the avian influenza virus. The clinical
trials are aimed at discovering the pharmacological effects and
recognizing the adverse reactions to vaccines used by humans. One of
the key issues associated with H5N1 vaccine production is the lack of
overall surge production capacity.
The data included in the report
comprises top level data related to the clinical trials by country,
region, trial status, trial phase, end point status, and sponsor
type. The study also reviews the top companies involved in these
clinical trials. In the first section, it provides analysis of
clinical trials by region. The key regions analyzed in the report are
Asia Pacific, the Middle East and Africa, Europe, North America, and
Central and South America. Then the study begins to evaluate the
clinical trials and the average enrollment in key nations. The top
five countries contributing to clinical trials in Europe, APAC, MEA,
North America, and Central and South America are covered.
Furthermore, the report presents
an evaluation of the clinical trials in G7 countries. This section
covers the proportion of H5N1 infection (bird flu) trials to
infectious disorders clinical trials. Moving on, the study presents a
detailed evaluation of the phases of these clinical trials.
Similarly, the data related to E7 countries is also mentioned by
trial status. Moreover, the end point status of these H5N1 infection
clinical trials is covered. The number of subjects recruited for
these trials and the period of time is also mentioned.
View
Press Release @ http://www.marketresearchreports.biz/pressrelease/877
Lastly, the report offers an
in-depth analysis of the several sponsor types in the global H5N1
infection clinical trials market. Several prominent sponsors and top
companies participating in these trials are discussed. Further to
this, a profile analysis of the most prominent drugs is also
evaluated. The report ends with an appendix listing definitions and
the research methodology.
About us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
Mr.
Nachiket
State
Tower
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-621-2074
No comments:
Post a Comment